(Reuters Health) – Continuous glucose monitoring devices may reduce episodes of dangerously-low blood sugar in adults with type 1 diabetes who suffer from so-called hypoglycemic unawareness, researchers say.
Source: Reuters Medical News
Doctor admits disclosing patient info to drugmaker Aegerion
BOSTON (Reuters) – A Georgia pediatric cardiologist pleaded guilty on Wednesday to wrongfully disclosing information about his young patients to an Aegerion Pharmaceuticals Inc sales representative seeking to identify potential new users of an expensive cholesterol drug.
Source: Reuters Medical News
Europe follows FDA with plans to help early Alzheimer's drugs
LONDON (Reuters) – European regulators are following in the footsteps of the U.S. Food and Drug Administration with plans to help pharmaceutical companies win approval for novel Alzheimer’s drugs that treat the earliest stages of the memory-robbing disease.
Source: Reuters Medical News
AstraZeneca spins off autoimmune drugs into new biotech company
LONDON (Reuters) – AstraZeneca is spinning off six early-stage experimental drugs into a new $250 million standalone biotech company focused on severe autoimmune diseases.
Source: Reuters Medical News
Mississippi moves closer to banning abortions after 15 weeks
(Reuters) – Mississippi moved a step closer on Tuesday to passing the United States’ most restrictive abortion law when a state Senate committee approved a bill banning most procedures after 15 weeks of gestation.
Source: Reuters Medical News
U.S. subpoenas Mallinckrodt for information on opioid painkillers
(Reuters) – Pharmaceutical company Mallinckrodt Plc said on Tuesday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to generic drugs it produces that contain the opioid painkiller oxymorphone.
Source: Reuters Medical News
U.S. to seek reimbursement from opioid makers, distributors
WASHINGTON (Reuters) – The federal government, backing litigation by states and cities, will seek reimbursement from major drug companies and distributors to recover costs it has borne from the opioid epidemic, the U.S. Justice Department said on Tuesday.
Source: Reuters Medical News
Many mothers may lack knowledge about child burn risk, treatment
(Reuters Health) – Mothers of young children may be largely unaware of the biggest burn risks to their little ones and even what age group is most likely to get burned, Australian researchers say.
Source: Reuters Medical News
U.S. FDA rejects filing for Celgene MS drug, shares fall
(Reuters) – U.S. health regulators have rejected Celgene Corp’s application seeking approval of a key multiple sclerosis drug due to insufficient data, the company said on Tuesday, a surprise development that will likely delay the entry to market of one of Celgene’s most important pipeline assets.
Source: Reuters Medical News
Aerobic exercise slows cognitive decline in Alzheimer’s disease
(Reuters Health) – Cardiovascular exercise training may help slow the decline in brain function seen in Alzheimer’s patients, a new review of past research suggests.
Source: Reuters Medical News